Rupee Opens 35 Paise Higher at 9534 Against US Dollar Amid Improved Risk Sentiment and RBI Support Zscaler Shares Plunge 31 on Cautious Outlook and Sales Restructuring The Economics of Live Music How Blue Dot Fever and Rising Prices Are Reshaping Concert Spending UK Chancellor Reeves Announces VAT Cuts for Theme Park Tickets and Childrens Meals to Ease CostofLiving Pressures Treasury Yields Dip Slightly as Iran Peace Deal Optimism Tempers Market Sentiment Taiwan Chip Stocks Rally as Nvidia Unveils 150 Billion Spending Plan Mainland Rivals Decline KULR Q3 2025 Earnings EPS Misses Estimates Sharply Despite Strong Market Reaction PRG Q1 2026 Earnings Massive EPS Beat Surprises But Market Response Remains Subdued WBD Q1 2026 Earnings Narrowed Loss Beats Estimates Amid Restructuring BMBL Q1 2026 Earnings EPS Surges Past Estimates with 224 Beat Gates Industrial GTES Q1 2026 Earnings EPS Beat Drives Modest Stock Gain Amid Cautious Outlook OCCI Q1 2026 Earnings Deep EPS Miss Overshadowed by Positive Market Reaction Bon Natural Life Limited BON Declines Slightly as Stock Hovers Near Key 12 Support Zone Indonesia Energy Corporation INDO Slides 241 as Shares Approach Critical Support Near 270 Inuvo Inc INUV Edges Higher as Price Stabilizes Near Key Support NeoGenomics NEO Navigates Narrow Range as Stock Hovers Near Support Live Nation Entertainment LYV Holds Steady Near Support as Market Weighs Event Demand VICR Q1 2026 Earnings EPS Surges Past Estimates with 1983 Beat ImageneBio IMA Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline XXII Q1 2026 Earnings Significant EPS Miss Highlights Continued Challenges TXO Partners Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Operational Challenges COLL Q1 2026 Earnings EPS Beats Estimates by 843 as Collegium Posts 176 MCHPP Q1 2026 Earnings Strong Earnings Beat Drives Positive Market Response EU Green Economy Output Doubles as Solar Energy Surges to Record Levels Good Times Restaurants Inc Q1 2026 Earnings Modest Profit Amid Undisclosed Revenue Vera Therapeutics VERA Consolidates Near Support After Slight Decline